572 VAD cases prove Victoria’s law safe, setting global precedent

For legal professionals and policymakers, the strength of a voluntary assisted dying law hinges on evidence that it can be safely implemented without unintended harm. This landmark study provides the strongest empirical foundation yet to support statutory frameworks, mitigate legal challenges, and guide legislative drafting worldwide.

Victoria, Australia, has produced the world's largest dataset on the use of oral, self-administered voluntary assisted dying (VAD) medication, providing compelling evidence of the method's safety and effectiveness. The study, led by Professor Michael Dooley of Monash University and the Victorian Voluntary Assisted Dying Statewide Pharmacy Service, tracked 572 terminally ill patients who self-administered the lethal compound between 2019 and 2025. Published on July 9, 2026, the research delivers a critical empirical foundation for jurisdictions worldwide grappling with end-of-life law reform.

“

The study, led by Professor Michael Dooley of Monash University and the Victorian Voluntary Assisted Dying Statewide Pharmacy Service, tracked 572 terminally ill patients who self-administered the lethal compound between 2019 and 2025.

Victoria's VAD legislation, enacted in June 2019, allowed eligible adults with an advanced, progressive, and terminal illness to request and receive a prescription for a self-administered lethal substance. The law required rigorous safeguards, including multiple medical assessments and a waiting period. However, the practical implementation of compounding and dispensing a lethal oral medication was uncharted territory. Professor Dooley and his team designed the protocol from a 'blank piece of paper,' drawing on variable international experiences, to create a system that would be safe, reliable, and respectful of patient autonomy.

The medication, a highly potent powdered sedative mixed into a liquid suspension, was delivered to patients' homes by specially trained pharmacists. Data collection relied on detailed reports from family members and caregivers, who observed the patient's final moments. The results were striking: every patient who consumed the dose died as a result. In over 98% of cases, the patient successfully swallowed the entire mixture in under four minutes, a crucial metric given the anxiety and physical decline that can complicate oral ingestion. Furthermore, approximately 93% of patients lost consciousness within 10 minutes, indicating a rapid and peaceful transition. Only a small fraction experienced vomiting or extended intervals to death, and even then, the outcome was always eventual death without prolonged suffering.

The magnitude of the dataset—572 patients over six years—makes it the largest of its kind globally for orally self-administered VAD medication. This robust sample size allows clinicians, policymakers, and researchers to draw statistically meaningful conclusions, moving beyond anecdotal evidence. It also provides a template for other jurisdictions, such as Oregon, Washington, and the Netherlands, though many of those programs rely more heavily on parenteral administration or have different legal frameworks.

From a regulatory perspective, the findings support the feasibility of a pharmacy-led, community-based VAD system. The Victorian model demonstrates that a centralized pharmacy service, with specially trained pharmacists, can safely compound and dispense lethal medication, ensure proper chain-of-custody, and gather follow-up data. This has direct implications for other Australian states, like New South Wales and Queensland, which have recently passed similar laws, and for international jurisdictions considering VAD legislation.

The study's publication in a peer-reviewed medical journal adds to the growing body of evidence that assisted dying can be medically safe when proper protocols are in place. It also provides a valuable ethical counterbalance to concerns that vulnerable populations might be coerced or that the process might be botched. The data shows that the medication works exactly as intended in nearly all cases, fulfilling the core promise of the law: to allow terminally ill individuals to die with dignity and on their own terms.

For the broader healthcare system, the research validates the role of pharmacists in end-of-life care. Professor Dooley's personal reflections—that he has become more aware of life's preciousness—underscore the human dimension of this work. The pharmacy service not only dispensed medication but also provided compassion and support, bridging a gap between clinical efficiency and patient-centered care.